Mair J, Artner-Dworzak E, Lechleitner P, Morass B, Smidt J, Wagner I, Dienstl F, Puschendorf B
Department of Medical Chemistry and Biochemistry, University of Innsbruck, Austria.
Br Heart J. 1992 Nov;68(5):462-8. doi: 10.1136/hrt.68.11.462.
To evaluate a rapid immunoturbidimetric assay for myoglobin and to investigate its clinical usefulness in the early detection of acute myocardial infarction.
Prospective study. Immunoturbidimetrically determined myoglobin concentrations were compared with radioimmunoassay results obtained with the same blood samples. The diagnostic performance of myoglobin determination was compared with creatine kinase and creatine kinase MB activity (current standard of routine diagnosis).
Part 1: coronary care unit. Part 2: emergency room in a university hospital.
Part 1:30 patients with acute myocardial infarction admitted not later than four hours (median two hours) after the onset of symptoms. Part 2: 126 patients admitted to the emergency room with chest pain not caused by trauma (51 cases of acute myocardial infarction, 51 cases of angina pectoris, and 24 cases of chest pain not related to coronary artery disease).
Part 1: routine treatment including intravenous thrombolytic treatment (28 patients). Part 2: routine emergency treatment without thrombolytic treatment.
The analytical quality of the immunoturbidimetric myoglobin assay and a comparison between the myoglobin assay and creatine kinase and creatine kinase MB for diagnostic sensitivity and performance.
The immunoturbidimetric myoglobin assay was fast and convenient and gave myoglobin determinations of high analytical quality. The concentration of myoglobin increased, peaked, and returned to the reference range significantly earlier than creatine kinase (p < or = 0.0001) and creatine kinase MB (p < or = 0.0002). Before thrombolytic therapy was started the diagnostic sensitivity of myoglobin was significantly higher than that of creatine kinase MB activity 0-6 h after the onset of chest pain and significantly higher (0.82 v 0.29) than creatine kinase 2-4 h after the onset of chest pain. In almost all patients (92%) plasma myoglobin concentrations were increased 4-6 h after the onset of chest pain.
Myoglobin was more sensitive in detecting early myocardial infarction than creatine kinase and creatine kinase MB activity. Immunoturbidimetric myoglobin measurements could be useful in the early evaluation of patients with suspected myocardial infarction because this assay takes less than two minutes.
评估肌红蛋白快速免疫比浊法,并研究其在急性心肌梗死早期检测中的临床应用价值。
前瞻性研究。将免疫比浊法测定的肌红蛋白浓度与用相同血样获得的放射免疫分析结果进行比较。将肌红蛋白测定的诊断性能与肌酸激酶及肌酸激酶同工酶活性(常规诊断的当前标准)进行比较。
第一部分:冠心病监护病房。第二部分:大学医院的急诊室。
第一部分:30例急性心肌梗死患者,症状发作后不迟于4小时(中位数为2小时)入院。第二部分:126例因胸痛入院急诊室且非外伤所致的患者(51例急性心肌梗死、51例心绞痛、24例与冠状动脉疾病无关的胸痛)。
第一部分:常规治疗,包括静脉溶栓治疗(28例患者)。第二部分:不进行溶栓治疗的常规急诊治疗。
免疫比浊法测定肌红蛋白的分析质量,以及肌红蛋白测定与肌酸激酶和肌酸激酶同工酶在诊断敏感性和性能方面的比较。
免疫比浊法测定肌红蛋白快速便捷,分析质量高。肌红蛋白浓度升高、达到峰值并恢复至参考范围的时间明显早于肌酸激酶(p≤0.0001)和肌酸激酶同工酶(p≤0.0002)。在开始溶栓治疗前,胸痛发作后0至6小时肌红蛋白的诊断敏感性显著高于肌酸激酶同工酶活性,胸痛发作后2至4小时显著高于肌酸激酶(0.82对0.29)。几乎所有患者(92%)胸痛发作后4至6小时血浆肌红蛋白浓度升高。
肌红蛋白在检测早期心肌梗死方面比肌酸激酶和肌酸激酶同工酶活性更敏感。免疫比浊法测定肌红蛋白可能有助于对疑似心肌梗死患者进行早期评估,因为该检测耗时不到两分钟。